• No results found

Investigation into what factors are responsible for switching on or off the Tissue Factor gene

N/A
N/A
Protected

Academic year: 2022

Share "Investigation into what factors are responsible for switching on or off the Tissue Factor gene"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Investigation into what factors are responsible for switching on or off the Tissue Factor gene

Hari vanaja Palisetty

Among all the different substances in the blood, Tissue Factor is the most important factor that helps in the formation of a blood clot during external injury, as this injury activates its function.

Under normal conditions, when there is no injury, its function is not necessary and is then switched off. Tissue Factor is also involved in clot formation inside the blood vessels in many diseases like cancer, heart disease, obesity and diabetes as then Tissue Factor is wrongly switched on.

In this study we tried to find out previously not known mechanisms that are responsible for switching Tissue Factor on or off as this can help in controlling its function in different diseases.

To investigate this we used specific cells that can grow in a laboratory and express Tissue Factor.

Treating these cells with different chemicals can switch off Tissue Factor in these cells, or switch it back on again. The information that regulates these switches is encoded in the genetic material, the DNA. We isolated genetic material from cells that had been treated with such substances so we had cells where Tissue Factor was either switched on or off. The genetic material from these two conditions was then compared using a specific technique that can detect differences in the genetic material between the two conditions.

We found that in some regions of the DNA there was a difference between the two conditions.

This tells us that in the regions that were different may hold some clues to the function of Tissue Factor in normal and disease conditions. If we could identify exactly what these differences are then it may be possible to design drugs that help switch off Tissue Factor in diseases where it is switched on incorrectly.

Degree project in Biology

Examensarbete i biologi (30hp), Uppsala universitet, 2012

Biology Education Centre and Department of Medical Sciences, Uppsala University Supervisor: Jenny Alfredsson, Ph.D

References

Related documents

Matrix metalloproteinase-1 (MMP-1) protein expression in tumour tissue and MMP-2 expression in plasma was associated with increasing tumour stage (T-status) and lymph node

Matrix metalloproteinase-1 (MMP-1) protein expression in tumour tissue and MMP-2 expression in plasma was associated with increasing tumour stage (T-status) and lymph node

Karin C arlsson Tissue F actor in C omplex - Studies of interactions between blood coagulation proteins

Using cell culture models, we found that antiapoptotic signaling by TF/FVIIa requires signaling by the Insulin-like growth factor I receptor (IGF-1R), as synthetic IGF-1R inhibitors

We report herein that TF and EphA2 co-localizes in MDA-MB-231 breast cancer cells with constitutive high TF expression and in TF transfected U251 glioblastoma cells, and that

obesity, GDM is a complex condition and it has been difficult for scientists to find an answer to the question why these children are more likely to become obese and they have not yet

The signaling can be dependent or independent of the protease activated receptors (PAR) PAR2 and PAR1, the TF cytoplasmic domain, by activation of integrins and

It has previously been reported that 3T3-L1 adipocytes and murine adipose tissue express FVII (30), but we now provide evidence for FVII expression in isolated human primary